Jim Simons acquired 1.24 Million Supernus Pharmaceuticals shares worth $34.2 Million. That's 0.05% of their equity portfolio (430th largest holding). The investor owns 2.36% of the outstanding Supernus Pharmaceuticals stock. The first Supernus Pharmaceuticals trade was made in Q3 2014. Since then Jim Simons bought shares twelve more times and sold shares on eleven occasions. The investor's estimated purchase price is $38.6 Million, resulting in a loss of 11%.